Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Filing Details

Accession Number:
0001104659-15-085325
Form Type:
4
Zero Holdings:
No
Publication Time:
2015-12-17 08:01:01
Reporting Period:
2015-12-16
Filing Date:
2015-12-17
Accepted Time:
2015-12-17 08:01:01
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1135906 Epirus Biopharmaceuticals Inc. EPRS Pharmaceutical Preparations (2834) 043514457
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1612551 Amit Munshi C/o Epirus Biopharmaceuticals, Inc.
699 Boylston Street, 8Th Floor
Boston MA 02116
Chief Executive Officer Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2015-12-16 8,270 $2.80 169,982 No 4 P Indirect See Footnote
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Indirect See Footnote
Footnotes
  1. All shares are held by the Amit D Munshi Revocable Trust Dated April 12, 2011, for which the Reporting Person serves as trustee.